Fierce Pharma21h
Novartis links music and science in corporate campaign tied to Eurovision sponsorship
Novartis was announced as an official partner of this year’s Eurovision competition last fall, after the song entry from ...
FDA Approves Expanded Use Of Novartis Rare Disease Drug As Only Treatment For Rare Type Of Kidney Disease
On Thursday, the U.S. Food and Drug Administration (FDA) approved Novartis AG’s (NYSE:NVS) oral Fabhalta (iptacopan) for ...
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Phase III study showed sustained proteinuria reduction at one yea ...
BioSpace2d
Novartis’ Intrathecal Zolgensma Effective in Older Children
After bringing Zolgensma to market in 2019 as the first gene therapy for spinal muscular atrophy, Novartis is back with an intrathecal formulation intended for older patients.
Spotlight On Sponsors: Pat Cash Signs On As Official Ambassador Of Kooyong Classic
The Kooyong Classic has welcomed tennis legend and former Wimbledon champion Pat Cash as an official ambassador for the ...
Indianapolis Recorder2d
NFL names Novartis first-ever corporate pharmaceutical partner
The National Football League (NFL) announced Novartis as its first-ever corporate pharmaceutical partner on March 13.
NJBIZ3d
NFL drafts Novartis as first pharmaceutical partner
The Swiss pharma giant – which has its U.S. headquarters in East Hanover – said it aims to encourage football fans to "proactively manage their health." ...